Home › Trial NCT00503711
Phase I Chinese PK
- Trial IDNCT00503711
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorGenzyme, a Sanofi Company
- Enrollment36
- Start date2006-09
- ConditionsAdvanced Solid, Malignant Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.